Multidimensional prognostic indices for use in COPD patient care. A systematic review

Respiratory Research

Volumn 12, Issue , 2011, Pages

  van Dijk, Wouter D ^a   van den Bemt, Lisette ^a   van den Haak Rongen, Saskia ^b   Bischoff, Erik ^a   van Weel, Chris ^a   in 't Veen, Johannes C C M ^c   Schermer, Tjard R J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b QUARTZ Integrated Care Support Service   (Netherlands)

^c SINT FRANCISCUS GASTHUIS   (Netherlands)

Author keywords

Copd; Index; Multidimensional; Prognosis

Indexed keywords

AIRWAY OBSTRUCTION; BODY MASS; BODY WEIGHT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; DISEASE EXACERBATION; DYSPNEA; EMBASE; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; GENDER; HOSPITALIZATION; HUMAN; MEDICAL LITERATURE; MEDLINE; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; PREDICTIVE VALUE; PROGNOSIS; REVIEW; RISK FACTOR; SCORING SYSTEM; SCREENING; SYSTEMATIC REVIEW; LUNG FUNCTION TEST; METHODOLOGY; PREVALENCE; PROPORTIONAL HAZARDS MODEL; REPRODUCIBILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICS; SURVIVAL; SURVIVAL RATE; UTILIZATION REVIEW;

DATA INTERPRETATION, STATISTICAL; HOSPITALIZATION; HUMANS; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 81055127633     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-12-151     Document Type: Review

References (67)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global Strategy for Diagnosis, Management, and Prevention of COPD (2010). Global Initiative for Chronic Obstructive Lung Disease (GOLD)., http://www.goldcopd.com
2. Mannino DM, Reichert MM, Davis KJ. Lung function decline and outcomes in an adult population. Am J Respir Crit Care Med 2006, 173(9):985-990. 10.1164/rccm.200508-1344OC, 16439715.
3. Anthonisen NR, Wright EC, Hodgkin JE, . IPPB Trial Group Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986, 133:14-20. IPPB Trial Group.
4. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008, 359(15):1543-1554. 10.1056/NEJMoa0805800, 18836213.
5. Yang IA, Fong KM, Sim EH, Black PN, Lasserson TJ. Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2007, (2):CD002991.
6. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007, 356(8):775-789. 10.1056/NEJMoa063070, 17314337.
7. van den Bemt L, Schermer TRJ. Multicomponent staging indices for COPD in daily patient care: what's the yield?. Int J Clin Pract 2010, 64(11):1475-1479. 10.1111/j.1742-1241.2010.02434.x, 20846194.
8. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007, 370(9589):765-773. 10.1016/S0140-6736(07)61380-4, 17765526.
9. Schunemann H. From BODE to ADO to outcomes in multimorbid COPD patients. Lancet 2009, 374(9691):667-668. 10.1016/S0140-6736(09)61539-7, 19716945.
10. Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, MacNee W, Make BJ, Rabe KF, Rennard SI, Sciurba FC, Silverman EK, Vestbo J, Washko GR, Wouters EF, Martinez FJ. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010, 182(5):598-604. 10.1164/rccm.200912-1843CC, 20522794.
11. Berry CE, Wise RA. Mortality in COPD: causes, risk factors, and prevention. COPD 2010, 7(5):375-382. 10.3109/15412555.2010.510160, 20854053.
12. Godtfredsen NS, Lam TH, Hansel TT, Leon ME, Gray N, Dresler C, Burns DM, Prescott E, Vestbo J. COPD-related morbidity and mortality after smoking cessation: status of the evidence. Eur Respir J 2008, 32(4):844-853. 10.1183/09031936.00160007, 18827152.
13. Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet 2003, 362(9387):847-852. 10.1016/S0140-6736(03)14338-3, 13678970.
14. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002, 121(5):1434-1440. 10.1378/chest.121.5.1434, 12006425.
15. Puhan MA, Garcia-Aymerich J, Frey M, ter Riet G, Anto JM, Agusti AG, Gomez FP, Rodriguez-Roisin R, Moons KG, Kessels AG, Held U. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 2009, 374(9691):704-711. 10.1016/S0140-6736(09)61301-5, 19716962.
16. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003, 167(4):544-549. 10.1164/rccm.200206-583OC, 12446268.
17. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 160(6):1856-1861.
18. Donaldson GC, Wedzicha JA. COPD exacerbations 1: Epidemiology. Thorax 2006, 61(2):164-168. 10.1136/thx.2005.041806, 2104564, 16443707.
19. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008, 32(4):962-969. 10.1183/09031936.00012408, 18579551.
20. Fan VS, Curtis JR, Tu SP, McDonell MB, Fihn SD. Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases. Chest 2002, 122(2):429-436. 10.1378/chest.122.2.429, 12171813.
21. Moons KG, Royston P, Vergouwe Y, Grobbee DE, Altman DG. Prognosis and prognostic research: what why and how?. BMJ 2009, 338:b375. 10.1136/bmj.b375, 19237405.
22. Altman DG, Vergouwe Y, Royston P, Moons KG. Prognosis and prognostic research: validating a prognostic model. BMJ 2009, 338:b605. 10.1136/bmj.b605, 19477892.
23. Moons KG, Altman DG, Vergouwe Y, Royston P. Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ 2009, 338:b606. 10.1136/bmj.b606, 19502216.
24. Hayden JA, Cote P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 2006, 144(6):427-437.
25. Fan VS, Ramsey SD, Make BJ, Martinez FJ. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD. COPD 2007, 4(1):29-39. 10.1080/15412550601169430, 17364675.
26. Atis S, Kanik A, Ozgur ES, Eker S, Tumkaya M, Ozge C. [How exactly can we predict the prognosis of COPD]. Tuberk Toraks 2009, 57(3):289-297.
27. Burgel PR, Paillasseur JL, Caillaud D, Tillie-Leblond I, Chanez P, Escamilla R, Court-Fortune Perez T, Carre P, Roche N. Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J 2010, 36(3):472-4. 10.1183/09031936.00035210, 20930198.
28. Bailey WC, Sciurba FC, Hanania NA, Donohue JF, Ferguson GT, Zibrak JD, Sharafkhaneh A, Marcus P, Rosa K, Piault EC, Martinez FJ. Development and validation of the Chronic Obstructive Pulmonary Disease Assessment Questionnaire (COPD-AQ). Prim Care Respir J 2009, 18(3):198-207. 10.4104/pcrj.2009.00032, 19492178.
29. Celli BR, Calverley PM, Rennard SI, Wouters EF, Agusti A, Anthonisen N, MacNee W, Jones P, Pride N, Rodriguez-Roisin R, Rossi A, Wanner A. Proposal for a multidimensional staging system for chronic obstructive pulmonary disease. Respir Med 2005, 99(12):1546-1554. 10.1016/j.rmed.2005.03.019, 16291077.
30. Eisner MD, Trupin L, Katz PP, Yelin EH, Earnest G, Balmes J, Blanc PD. Development and validation of a survey-based COPD severity score. Chest 2005, 127(6):1890-1897. 10.1378/chest.127.6.1890, 15947299.
31. Jones P, Harding G, Wiklund I, Berry P, Leidy N. Improving the process and outcome of care in COPD: development of a standardised assessment tool. Prim Care Respir J 2009, 18(3):208-215. 10.4104/pcrj.2009.00053, 19690787.
32. Miravitlles M, Llor C, de Castellar R, Izquierdo I, Baro E, Donado E. Validation of the COPD severity score for use in primary care: the NEREA study. Eur Respir J 2009, 33(3):519-527. 10.1183/09031936.00087208, 19164354.
33. Peters JB, Daudey L, Heijdra YF, Molema J, Dekhuijzen PN, Vercoulen JH. Development of a battery of instruments for detailed measurement of health status in patients with COPD in routine care: the Nijmegen Clinical Screening Instrument. Qual Life Res 2009, 18(7):901-912. 10.1007/s11136-009-9502-2, 2724638, 19543807.
34. Selim AJ, Ren XS, Fincke G, Rogers W, Lee A, Kazis LA. Symptom-based measure of the severity of chronic lung disease: results from the Veterans Health Study. Chest 1997, 111(6):1607-1614. 10.1378/chest.111.6.1607, 9187183.
35. Vercoulen JH, Daudey L, Molema J, Vos PJ, Peters JB, Top M, Folgering H. An Integral assessment framework of health status in chronic obstructive pulmonary disease (COPD). Int J Behav Med 2008, 15(4):263-279. 10.1080/10705500802365474, 19005926.
36. Verhage TL, Heijdra YF, Molema J, Daudey L, Dekhuijzen PN, Vercoulen JH. Adequate Patient Characterization in COPD: Reasons to Go Beyond GOLD Classification. Open Respir Med J 2009, 3:1-9. 10.2174/1874306400903010001, 2682926, 19452033.
37. Wu EQ, Birnbaum HG, Cifaldi M, Kang Y, Mallet D, Colice G. Development of a COPD severity score. Curr Med Res Opin 2006, 22(9):1679-1687. 10.1185/030079906X115621, 16968571.
38. Yeh ML, Chen HH, Liao YC, Liao WY. Testing the functional status model in patients with chronic obstructive pulmonary disease. J Adv Nurs 2004, 48(4):342-350. 10.1111/j.1365-2648.2004.03203.x, 15500528.
39. Cote CG, Celli BR. BODE index: a new tool to stage and monitor progression of chronic obstructive pulmonary disease. Pneumonol Alergol Pol 2009, 77(3):305-313.
40. Martinez FJ, Han MK, Andrei AC, Wise R, Murray S, Curtis JL, Sternberg A, Criner G, Gay SE, Reilly J, Make B, Ries AL, Sciurba F, Weinmann G, Mosenifar Z, DeCamp M, Fishman AP, Celli BR. Longitudinal change in the BODE index predicts mortality in severe emphysema. Am J Respir Crit Care Med 2008, 178(5):491-499. 10.1164/rccm.200709-1383OC, 2542428, 18535255.
41. Ong KC, Earnest A, Lu SJ. A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest 2005, 128(6):3810-3816. 10.1378/chest.128.6.3810, 16354849.
42. Howell S, Coory M, Martin J, Duckett S. Using routine inpatient data to identify patients at risk of hospital readmission. BMC Health Serv Res 2009, 9:96. 10.1186/1472-6963-9-96, 2700797, 19505342.
43. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The Body-Mass Index Airflow Obstruction Dyspnea and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease. N Engl J Med 2004, 350(10):1005-1012. 10.1056/NEJMoa021322, 14999112.
44. Esteban C, Quintana JM, Aburto M, Moraza J, Capelastegui A. A simple score for assessing stable chronic obstructive pulmonary disease. QJM 2006, 99(11):751-759. 10.1093/qjmed/hcl110, 17030529.
45. American Thoracic Society Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995, 152:S77-S120. American Thoracic Society.
46. American Thoracic Society Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991, 144:1202-1218. American Thoracic Society.
47. Omachi TA, Yelin EH, Katz PP, Blanc PD, Eisner MD. The COPD severity score: a dynamic prediction tool for health-care utilization. COPD 2008, 5(6):339-346. 10.1080/15412550802522700, 2667628, 19353347.
48. Briggs A, Spencer M, Wang H, Mannino D, Sin DD. Development and validation of a prognostic index for health outcomes in chronic obstructive pulmonary disease. Arch Intern Med 2008, 168(1):71-79. 10.1001/archinternmed.2007.37, 18195198.
49. Kostianev SS, Hodgev VA, Iluchev DH. Multidimensional system for assessment of COPD patients Comparison with BODE index. Folia Med (Plovdiv) 2008, 50(4):29-38.
50. Mehrotra N, Freire AX, Bauer DC, Harris TB, Newman AB, Kritchevsky SB, Meibohm B. Predictors of mortality in elderly subjects with obstructive airway disease: the PILE score. Ann Epidemiol 2010, 20(3):223-232. 10.1016/j.annepidem.2009.11.005, 2827353, 20159492.
51. Soler-Cataluna JJ, Martinez-Garcia MA, Sanchez LS, Tordera MP, Sanchez PR. Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients. Respir Med 2009, 103(5):692-699. 10.1016/j.rmed.2008.12.005, 19131231.
52. Jones RC, Donaldson GC, Chavannes NH, Kida K, Dickson-Spillmann M, Harding S, Wedzicha JA, Price D, Hyland ME. Derivation and Validation of a Composite Index of Severity in Chronic Obstructive Pulmonary Disease - The DOSE Index. Am J Respir Crit Care Med 2009, 180(12):1189-95. 10.1164/rccm.200902-0271OC, 19797160.
53. Niewoehner DE, Lokhnygina Y, Rice K, Kuschner W, Sharafkhaneh A, Sarosi GA, Krumpe P, Pieper K, Kesten S. Risk indexes for exacerbations and hospitalizations due to COPD. Chest 2007, 131:20-28. 10.1378/chest.06-1316, 17218552.
54. Azarisman MS, Fauzi MA, Faizal MP, Azami Z, Roslina AM, Roslan H. The SAFE (SGRQ score air-flow limitation and exercise tolerance) Index: a new composite score for the stratification of severity in chronic obstructive pulmonary disease. Postgrad Med J 2007, 83(981):492-497. 10.1136/pgmj.2006.052399, 2600092, 17621621.
55. Cardoso F, Tufanin AT, Colucci M, Nascimento O, Jardim JR. Replacement of the 6-min walk test with maximal oxygen consumption in the BODE Index applied to patients with COPD: an equivalency study. Chest 2007, 132(2):477-482. 10.1378/chest.07-0435, 17505032.
56. Schembri S, Anderson W, Morant S, Winter J, Thompson P, Pettitt D, MacDonald TM, Winter JH. A predictive model of hospitalisation and death from chronic obstructive pulmonary disease. Respir Med 2009, 103(10):1461-1467. 10.1016/j.rmed.2009.04.021, 19515547.
57. Gruffydd-Jones K, Richman J, Jones RC, Wang X. A pilot study of identification and case management of high-risk COPD patients in a general practice. Fam Pract 2010, 27(5):494-8. 10.1093/fampra/cmq045, 20631057.
58. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, de Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, et al. European guidelines on cardiovascular disease prevention in clinical practice: full text Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007, 14(Suppl 2):S1-113.
59. van den Bemt L, Smeele I, van Weel C. Prognostic assessment of patients with COPD. Lancet 2009, 374(9705):1886-1887.
60. Wildman MJ, Sanderson C, Groves J, Reeves BC, Ayres J, Harrison D, Young D, Rowan K. Implications of prognostic pessimism in patients with chronic obstructive pulmonary disease (COPD) or asthma admitted to intensive care in the UK within the COPD and asthma outcome study (CAOS): multicentre observational cohort study. BMJ 2007, 335(7630):1132. 10.1136/bmj.39371.524271.55, 2099544, 17975254.
61. Siebeling L, ter Riet G, van der Wal WM, Geskus RB, Zoller M, Muggensturm P, Joleska I, Puhan MA. ICE COLD ERIC--International collaborative effort on chronic obstructive lung disease: exacerbation risk index cohorts--study protocol for an international COPD cohort study. BMC Pulm Med 2009, 9:15. 10.1186/1471-2466-9-15, 2688483, 19419546.
62. Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, Hagan G, Knobil K, Lomas DA, MacNee W, Silverman EK, Tal-Singer R. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J 2008, 31(4):869-873. 10.1183/09031936.00111707, 18216052.
63. Esteban C, Quintana JM, Moraza J, Aburto M, Aguirre U, Aguirregomoscorta JI, Aizpiri S, Basualdo LV, Capelastegui A. BODE-Index vs HADO-score in chronic obstructive pulmonary disease: Which one to use in general practice?. BMC Med 2010, 8:28. 10.1186/1741-7015-8-28, 2880999, 20497527.
64. Cote CG, Celli BR. Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J 2005, 26(4):630-636. 10.1183/09031936.05.00045505, 16204593.
65. Nasis IG, Vogiatzis I, Stratakos G, Athanasopoulos D, Koutsoukou A, Daskalakis A, Spetsioti S, Evangelodimou A, Roussos C, Zakynthinos S. Effects of interval-load versus constant-load training on the BODE index in COPD patients. Respir Med 2009, 103(9):1392-1398. 10.1016/j.rmed.2009.03.003, 19349153.
66. Weston AD, Hood L. Systems biology proteomics and the future of health care: toward predictive preventative and personalized medicine. J Proteome Res 2004, 3(2):179-196. 10.1021/pr0499693, 15113093.
67. Wildman MJ, Sanderson C, Groves J, Reeves BC, Ayres J, Harrison D, Young D, Rowan K. Predicting mortality for patients with exacerbations of COPD and Asthma in the COPD and Asthma Outcome Study (CAOS). QJM 2009, 102(6):389-399. 10.1093/qjmed/hcp036, 19369483.